Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta
Authors:
- Yong Seok ChoiYCYong Seok Choi
- Jin Kyun ParkJPJin Kyun Park
- Eun Ha KangEKEun Ha Kang
- Young-Kyun LeeYLYoung-Kyun Lee
- Tae Kyun KimTKTae Kyun Kim
- Jin-Haeng ChungJCJin-Haeng Chung
- Jason M ZimmererJZJason M Zimmerer
- William E CarsonIIIWCWilliam E CarsonIII
- Yeong Wook SongYSYeong Wook Song
- Yun Jong LeeYLYun Jong Lee
Open Access
- 18 November 2013
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 15 (6) , R191
Abstract
Introduction: Although IL-1β is believed to be crucial in the pathogenesis of osteoarthritis (OA), the IL-1β blockade brings no therapeutic benefit in human OA and results in OA aggravation in several animal models. We explored the role of a cytokine signaling 1 (SOCS1) suppressor as a regulatory modulator of IL-1β signaling in chondrocytes. Methods: Cartilage samples were obtained from patients with knee OA and those without OA who underwent surgery for femur-neck fracture. SOCS1 expression in cartilage was assessed with immunohistochemistry. IL-1β-induced SOCS1 expression in chondrocytes was analyzed with quantitative polymerase chain reaction and immunoblot. The effect of SOCS1 on IL-1β signaling pathways and the synthesis of matrix metalloproteinases (MMPs) and aggrecanase-1 was investigated in SOCS1-overexpressing or -knockdown chondrocytes. Results: SOCS1 expression was significantly increased in OA cartilage, especially in areas of severe damage (P < 0.01). IL-1β stimulated SOCS1 mRNA expression in a dose-dependent pattern (P < 0.01). The IL-1β-induced production of MMP-1, MMP-3, MMP-13, and ADAMTS-4 (aggrecanase-1, a disintegrin and metalloproteinase with thrombospondin motifs 4) was affected by SOCS1 overexpression or knockdown in both SW1353 cells and primary human articular chondrocytes (all P values < 0.05). The inhibitory effects of SOCS1 were mediated by blocking p38, c-Jun N-terminal kinase (JNK), and nuclear factor κB (NF-κB) activation, and by downregulating transforming growth factor-β-activated kinase 1 (TAK1) expression. Conclusions: Our results show that SOCS1 is induced by IL1-β in OA chondrocytes and suppresses the IL-1β-induced synthesis of matrix-degrading enzymes by inhibiting IL-1β signaling at multiple levels. It suggests that the IL-1β-inducible SOCS1 acts as a negative regulator of the IL-1β response in OA cartilage.Keywords
This publication has 41 references indexed in Scilit:
- A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the kneeArthritis Research & Therapy, 2011
- Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritisBiochemical and Biophysical Research Communications, 2011
- Adiponectin is a potential catabolic mediator in osteoarthritis cartilageArthritis Research & Therapy, 2010
- SOCS1, SOCS3, and PIAS1 Promote Myogenic Differentiation by Inhibiting the Leukemia Inhibitory Factor-Induced JAK1/STAT1/STAT3 PathwayMolecular and Cellular Biology, 2009
- Structural and functional analysis of a nuclear localization signal in SOCS1Molecular Immunology, 2009
- Identification of a nuclear localization signal in suppressor of cytokine signaling 1The FASEB Journal, 2008
- Hormonal Regulation of Suppressors of Cytokine Signaling (SOCS) Messenger Ribonucleic Acid in the Arcuate Nucleus during Late PregnancyEndocrinology, 2008
- SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisJournal of Clinical Investigation, 2006
- Molecular mechanisms of cartilage destruction: Mechanics, inflammatory mediators, and aging collideArthritis & Rheumatism, 2006
- SOCS1: a potent and multifaceted regulator of cytokines and cell‐mediated inflammationTissue Antigens, 2005